Published in J Neurosurg on July 01, 1989
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol (2010) 2.45
Challenges in image-guided therapy system design. Neuroimage (2007) 1.61
Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys (2010) 1.58
Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol (2007) 1.24
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys (2008) 1.22
Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int (2014) 1.18
Practical guidelines for the treatment of malignant gliomas. West J Med (1998) 1.11
Chemotherapy for high-grade gliomas. Br J Cancer (2000) 1.09
Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. J Neurooncol (2009) 1.02
Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas. Radiat Oncol (2010) 0.99
Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med (2009) 0.95
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas. Core Evid (2010) 0.94
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma. Neuro Oncol (2004) 0.91
Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol (2014) 0.91
Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment. Neoplasia (2005) 0.88
Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS). Hum Gene Ther (2012) 0.88
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States. Neuro Oncol (2013) 0.87
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide. Radiat Oncol (2014) 0.84
Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiat Oncol (2012) 0.81
Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann Transl Med (2016) 0.80
Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. J Neurol Neurosurg Psychiatry (1998) 0.79
Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve. Br J Cancer (2016) 0.79
Combined modality approaches in the management of adult glioblastoma. Front Oncol (2011) 0.78
Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg (2012) 0.77
Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival? Stem Cells Int (2016) 0.76
Treatment of Gliomas: How did we get here? Surg Neurol Int (2015) 0.76
Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group. Radiat Oncol (2015) 0.76
The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. J Med Radiat Sci (2016) 0.75
Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas. Oncol Lett (2016) 0.75
Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review. Onco Targets Ther (2016) 0.75
Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy. Sci Rep (2017) 0.75
The treatment of primary malignant brain tumours. J Neurol Neurosurg Psychiatry (1991) 0.75
Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy. Mol Clin Oncol (2016) 0.75
Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma. J Korean Med Sci (2013) 0.75
Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center. Wien Klin Wochenschr (2003) 0.75
The role of radiation in treating glioblastoma: here to stay. J Neurooncol (2017) 0.75
Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiat Res (2017) 0.75
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol (1985) 11.38
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med (1995) 9.10
The new WHO classification of brain tumours. Brain Pathol (1993) 7.16
The ecological fallacy. Am J Epidemiol (1988) 6.38
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg (1978) 4.55
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med (1993) 4.28
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol (2000) 3.61
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet (2001) 3.48
State laws on youth access to tobacco in the United States: measuring their extensiveness with a new rating system. Tob Control (1998) 2.85
Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol (1999) 2.68
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer (1985) 2.59
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys (1979) 2.54
Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology (1994) 2.51
Subacute sclerosing panencephalitis: propagation of measles virus from brain biopsy in tissue culture. Science (1969) 2.43
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest (1993) 2.42
Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke (1991) 2.42
MR detection of brain iron. AJNR Am J Neuroradiol (1993) 2.39
On design considerations and randomization-based inference for community intervention trials. Stat Med (1996) 2.25
Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol (2000) 2.19
Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res (1992) 2.17
The benign course of cavernous carotid artery aneurysms. J Neurosurg (1992) 2.15
Surgical experience with an implanted artificial cervical joint. J Neurosurg (1998) 2.13
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology (1994) 2.12
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst (1996) 2.12
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol (1986) 2.07
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol (1991) 2.05
The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol (1973) 2.02
Ocular hypertelorism and pseudohypertelorism. Advances in surgical treatment. Plast Reconstr Surg (1970) 2.01
Efficacy of methylprednisolone in acute spinal cord injury. JAMA (1984) 1.99
Symptomatic Chiari malformations. An analysis of presentation, management, and long-term outcome. J Neurosurg (1989) 1.95
Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol (1999) 1.93
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene (1999) 1.91
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients. J Neurosurg (1988) 1.90
Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg (1999) 1.87
Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg (1983) 1.86
Histopathology, classification, and grading of gliomas. Glia (1995) 1.84
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg (1991) 1.81
Phenobarbital-induced fine structural changes in rat liver. Am J Pathol (1966) 1.80
Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol (1998) 1.76
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1985) 1.76
The prognosis of encephaloceles. J Neurosurg (1970) 1.69
Increasing incidence of primary brain lymphoma in the US. Cancer (1988) 1.68
Association between peridural scar and recurrent radicular pain after lumbar discectomy: magnetic resonance evaluation. ADCON-L European Study Group. Neurosurgery (1996) 1.66
Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus. J Neurosurg (1979) 1.65
Season of birth and risk of brain tumors in adults. Neurology (2004) 1.64
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol (1993) 1.62
Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg (1976) 1.62
How Many Subjects Does It Take To Do A Regression Analysis. Multivariate Behav Res (1991) 1.61
The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors. Neurosurgery (1990) 1.61
Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. J Clin Oncol (1991) 1.60
Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol (2001) 1.59
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer (1987) 1.58
Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery (1990) 1.58
Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol (1998) 1.56
Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol (1997) 1.53
Chordoid glioma: a neoplasm unique to the hypothalamus and anterior third ventricle. AJNR Am J Neuroradiol (2001) 1.53
Radiation-induced intracranial malignant gliomas. J Neurosurg (1989) 1.53
Specific chromosomal abnormalities in malignant human gliomas. Cancer Res (1988) 1.51
Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol (1985) 1.51
Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer (1999) 1.49
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology (2011) 1.48
Free radicals in cerebral ischemia. Stroke (1978) 1.48
Brain abscess due to Actinobacillus actinomycetemcomitans. Neurology (1967) 1.48
Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg (1998) 1.46
Inflammatory reaction to synthetic dural substitute. Case report. J Neurosurg (1989) 1.45
Preliminary experience with ultrasonic aspiration in neurosurgery. Neurosurgery (1979) 1.45
Degeneration of the central nervous system associated with celiac disease. J Neurol Sci (1982) 1.44
Wernicke encephalopathy following prolonged intravenous therapy. JAMA (1976) 1.43
The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neurooncol (1995) 1.43
Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg (1990) 1.43